NO20061678L - NOGO-A bindingsmolekyler og funmsoytiske anvendelser derav - Google Patents
NOGO-A bindingsmolekyler og funmsoytiske anvendelser deravInfo
- Publication number
- NO20061678L NO20061678L NO20061678A NO20061678A NO20061678L NO 20061678 L NO20061678 L NO 20061678L NO 20061678 A NO20061678 A NO 20061678A NO 20061678 A NO20061678 A NO 20061678A NO 20061678 L NO20061678 L NO 20061678L
- Authority
- NO
- Norway
- Prior art keywords
- binding molecule
- human
- phytosocial
- nogo
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0321997.9A GB0321997D0 (en) | 2003-09-19 | 2003-09-19 | Organic compound |
PCT/EP2004/010489 WO2005028508A2 (en) | 2003-09-19 | 2004-09-17 | Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061678L true NO20061678L (no) | 2006-06-16 |
Family
ID=29266310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061678A NO20061678L (no) | 2003-09-19 | 2006-04-12 | NOGO-A bindingsmolekyler og funmsoytiske anvendelser derav |
Country Status (25)
Country | Link |
---|---|
US (2) | US20090181023A1 (es) |
EP (3) | EP2423225A3 (es) |
JP (1) | JP2007527232A (es) |
KR (1) | KR20060119982A (es) |
CN (1) | CN1878792A (es) |
AR (1) | AR045671A1 (es) |
AU (2) | AU2004274164B2 (es) |
BR (1) | BRPI0414174B8 (es) |
CA (1) | CA2538725C (es) |
CO (1) | CO5680457A2 (es) |
EC (1) | ECSP066431A (es) |
GB (1) | GB0321997D0 (es) |
IL (2) | IL174145A (es) |
IS (1) | IS8404A (es) |
MA (1) | MA28088A1 (es) |
MY (2) | MY161068A (es) |
NO (1) | NO20061678L (es) |
NZ (1) | NZ545679A (es) |
PE (1) | PE20050949A1 (es) |
RU (1) | RU2380377C2 (es) |
SG (1) | SG146660A1 (es) |
TN (1) | TNSN06085A1 (es) |
TW (1) | TWI372060B (es) |
WO (1) | WO2005028508A2 (es) |
ZA (1) | ZA200601842B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1711530T3 (pl) * | 2003-12-22 | 2010-01-29 | Glaxo Group Ltd | Immunoglobuliny neutralizujące Nogo-A do leczenia chorób neurologicznych |
SG157418A1 (en) * | 2004-12-01 | 2009-12-29 | Univ Singapore | Nogo a protein fragments as neuronal network- interacting peptides |
PL1899377T3 (pl) * | 2005-07-05 | 2013-01-31 | Glaxo Group Ltd | Humanizowane przeciwciała specyficzne dla nogo-a i ich zastosowania farmaceutyczne |
GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
AU2008317724B2 (en) | 2007-11-02 | 2011-06-02 | Novartis Ag | Improved Nogo-A binding molecules and pharmaceutical use thereof |
US8828390B2 (en) | 2010-07-09 | 2014-09-09 | Universitat Zurich | Uses of NOGO-A inhibitors and related methods |
KR20150036398A (ko) | 2012-07-05 | 2015-04-07 | 글락소 그룹 리미티드 | 근육위축가쪽경화증의 치료에서의 항nogoa 항체의 최적 투여 섭생 |
CN113527462B (zh) * | 2020-04-22 | 2023-05-23 | 北京大学 | 一种具有镇痛作用的小分子肽及其特异性抗体 |
CN114470197B (zh) * | 2022-02-16 | 2023-10-03 | 天津长和生物技术有限公司 | 低氧培养的hUCMSC联合NogoA抗体在脊髓损伤治疗中的应用 |
WO2024041450A1 (zh) * | 2022-08-22 | 2024-02-29 | 舒泰神(北京)生物制药股份有限公司 | 特异性识别Nogo-A的抗体及其应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8308573D0 (en) | 1983-03-29 | 1983-05-05 | British Nuclear Fuels Ltd | Filament impregnating/coating |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
JP2904918B2 (ja) | 1989-02-13 | 1999-06-14 | シェーリング アクチェンゲゼルシャフト | 新規血栓溶解剤 |
WO2000005364A1 (en) * | 1998-07-22 | 2000-02-03 | Smithkline Beecham Plc | Protein similar to neuroendrocrine-specific protein, and encoding cdna |
KR100828058B1 (ko) * | 2000-01-12 | 2008-05-09 | 예일 유니버시티 | Nogo 수용체가 매개하는 축삭 성장의 차단 |
CA2468733C (en) * | 2001-11-30 | 2013-06-11 | Biogen Idec Ma Inc. | Antibodies against monocyte chemotactic proteins |
GB0228832D0 (en) * | 2002-12-10 | 2003-01-15 | Novartis Ag | Organic compound |
PL1711530T3 (pl) * | 2003-12-22 | 2010-01-29 | Glaxo Group Ltd | Immunoglobuliny neutralizujące Nogo-A do leczenia chorób neurologicznych |
-
2003
- 2003-09-19 GB GBGB0321997.9A patent/GB0321997D0/en not_active Ceased
-
2004
- 2004-09-16 AR ARP040103334A patent/AR045671A1/es unknown
- 2004-09-17 EP EP10176103A patent/EP2423225A3/en not_active Withdrawn
- 2004-09-17 NZ NZ545679A patent/NZ545679A/en not_active IP Right Cessation
- 2004-09-17 US US10/572,434 patent/US20090181023A1/en not_active Abandoned
- 2004-09-17 KR KR1020067005424A patent/KR20060119982A/ko not_active Application Discontinuation
- 2004-09-17 BR BRPI0414174A patent/BRPI0414174B8/pt not_active IP Right Cessation
- 2004-09-17 JP JP2006526602A patent/JP2007527232A/ja active Pending
- 2004-09-17 AU AU2004274164A patent/AU2004274164B2/en not_active Ceased
- 2004-09-17 MY MYPI2013003188A patent/MY161068A/en unknown
- 2004-09-17 MY MYPI20043786A patent/MY158078A/en unknown
- 2004-09-17 WO PCT/EP2004/010489 patent/WO2005028508A2/en active Application Filing
- 2004-09-17 CA CA2538725A patent/CA2538725C/en not_active Expired - Fee Related
- 2004-09-17 EP EP04765380A patent/EP1668033A2/en not_active Withdrawn
- 2004-09-17 PE PE2004000908A patent/PE20050949A1/es not_active Application Discontinuation
- 2004-09-17 RU RU2006112849/13A patent/RU2380377C2/ru active
- 2004-09-17 CN CNA2004800332675A patent/CN1878792A/zh active Pending
- 2004-09-17 EP EP10160905A patent/EP2248827A1/en not_active Withdrawn
- 2004-09-17 TW TW093128254A patent/TWI372060B/zh not_active IP Right Cessation
- 2004-09-17 SG SG200806933-8A patent/SG146660A1/en unknown
-
2006
- 2006-03-03 ZA ZA200601842A patent/ZA200601842B/en unknown
- 2006-03-06 IL IL174145A patent/IL174145A/en active IP Right Grant
- 2006-03-17 TN TNP2006000085A patent/TNSN06085A1/en unknown
- 2006-03-17 EC EC2006006431A patent/ECSP066431A/es unknown
- 2006-03-29 CO CO06031001A patent/CO5680457A2/es active IP Right Grant
- 2006-04-07 MA MA28921A patent/MA28088A1/fr unknown
- 2006-04-10 IS IS8404A patent/IS8404A/is unknown
- 2006-04-12 NO NO20061678A patent/NO20061678L/no not_active Application Discontinuation
-
2009
- 2009-01-22 AU AU2009200237A patent/AU2009200237B2/en not_active Ceased
- 2009-12-28 IL IL203007A patent/IL203007A/en active IP Right Grant
-
2010
- 2010-06-16 US US12/816,964 patent/US20110008334A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061678L (no) | NOGO-A bindingsmolekyler og funmsoytiske anvendelser derav | |
NO20092331L (no) | LINGO-bindingsmolekyler og farmasoytisk anvendelse derav | |
CY1110848T1 (el) | Αντισωμα αντι ανθρωπου νοgo α kai h φαρμακευτικη του χρηση | |
NO20064059L (no) | Albumin fusjonsproteiner | |
BRPI0413728B8 (pt) | muteína da lipocalina da lágrima humana, métodos para geração e para produção de muteína, composição farmacêutica e uso de muteína | |
EE05075B1 (et) | POL1212 aminohappejrjestust kodeeriv DNA, seda sisaldav ekspressioonivektor, sea modifitseeritud VIII-tegur, sellel p?hinev ravimkompositsioon ning meetod sea modifitseeritud VIII-teguri aminohappejrjestust omava valgu valmistamiseks | |
CO6470863A2 (es) | Mutantes fgf21 y usos de los mismos | |
NO20091734L (no) | Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse | |
NO20055919L (no) | 3-Subtituerte,5,6-Diaryl-Pyrazin-2-Karboksamid og 2-Sulfonamidderivater som CB1-Modulatorar | |
Khavinson et al. | Peptide regulation of gene expression: A systematic review | |
Cai et al. | Metal-assisted assembly and stabilization of collagen-like triple helices | |
Nagaoka et al. | Characterization of Genipin‐Modified Dentin Collagen | |
MY149546A (en) | Improved nogo-a binding molecules and pharmaceutical use tereof | |
SE0301987D0 (sv) | New polypeptide | |
TH71697A (th) | โมเลกุลสำหรับจับ nogo-a และการใช้สารเหล่านี้ในทางยา | |
WO2005005668A3 (en) | Diagnosis and treatment methods related to aging (8a) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |